The Healthcare Communications Association (HCA) has appointed Alice Choi, chief operating officer at McCann Health Medical Communications, as its new chairperson.
Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.